BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of novel 5-(imidazolyl-methyl) thiazolidinediones as antidiabetic agents. 2021

Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

A newly designed series of imidazolyl-methyl- l-2,4-thiazolidinediones 9 (a-m) were synthesized and In Silico studies were carried out to rationalize their anti-diabetic activity. Generally, all newly synthesized thiazolidinediones had anti-hyperglycemic activity compared with a diabetic-control group, without toxicity in 3T3 cells (viability ≥ 90%). These studies revealed that the compounds 9e and 9b (11∗10-6mol/kg) lowered blood glucose more effectively when compared to pioglitazone at the same dose. Following the administration of compound 9e, no weight gains or any serious side effects on liver and pancreas were observed. Moreover, the glucose consumption assay results showed a significant glucose-lowering effect (p < 0.001) in HepG2 cells, which were exposed to 11 mM of glucose at concentrations of 1.25-10 mM of compound 9e. Also, the PPAR-γ gene expression study revealed that pioglitazone and 9e showed similar behavior relative to the control group.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077205 Pioglitazone A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. Pioglitazone Hydrochloride,5-(4-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione,AD 4833,AD-4833,Actos,U 72107A,U-72107A,U72,107A,AD4833,U72107A
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Novel sulfonamide derivatives as multitarget antidiabetic agents: design, synthesis, and biological evaluation.
February 2024, RSC advances,
Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents.
January 2020, Bioorganic chemistry,
Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Design, synthesis, and biological evaluation of novel peptide Gly(3) -MC62 analogues as potential antidiabetic agents.
November 2015, Chemical biology & drug design,
Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.
February 2016, European journal of medicinal chemistry,
Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Design and synthesis of novel potent antinociceptive agents: methyl-imidazolyl N-acylhydrazone derivatives.
September 2000, Bioorganic & medicinal chemistry,
Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Design, Synthesis and Biological Evaluation of 1-methyl-1H-pyrazole-5-Carboxamide Derivatives as Novel Anti-Prostate Cancer Agents.
January 2021, Anti-cancer agents in medicinal chemistry,
Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Design, synthesis and biological evaluation of novel 5-hydroxy-2-methyl-4H-pyran-4-one derivatives as antiglioma agents.
March 2018, MedChemComm,
Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Design, synthesis and pharmacological evaluation of novel vanadium-containing complexes as antidiabetic agents.
January 2014, PloS one,
Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents.
March 2010, Bioorganic & medicinal chemistry,
Neda Shakour, and Amirhossein Sahebkar, and Gholamreza Karimi, and Maryam Paseban, and Aida Tasbandi, and Fatemeh Mosaffa, and Zahra Tayarani-Najaran, and Razieh Ghodsi, and Farzin Hadizadeh
Design, synthesis and biological evaluation of novel imidazopyridines as potential antidiabetic GSK3β inhibitors.
July 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!